Related Experiment Video

Updated: Jun 12, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Biomarkers of plaque instability in acute coronary syndrome patients

Jasmina Nurkic1, Farid Ljuca, Midhat Nurkic

  • 1Department of Immunology, Polyclinic for Laboratory Diagnostics, University Clinical Centre Tuzla, Bosnia and Herzegovina. jnurki@yahoo.com

Medicinski Arhiv
|June 3, 2010
PubMed

Insights

Serum levels of matrix metalloproteinase 9 (MMP-9) and C-reactive protein (hsCRP) can help assess acute coronary syndrome (ACS) patients. Elevated MMP-9 and hsCRP indicate higher risks, aiding in identifying plaque instability.

Area of Science:

  • Biochemistry
  • Cardiology
  • Biomarkers

Background:

  • Acute coronary syndrome (ACS) is a critical cardiovascular condition.
  • Matrix metalloproteinase 9 (MMP-9) and high-sensitivity C-reactive protein (hsCRP) are implicated in cardiovascular disease.
  • Biomarkers for plaque instability are crucial for ACS patient assessment.

Purpose of the Study:

  • To determine serum levels of MMP-9 and hsCRP in patients with ACS.
  • To compare these levels across patient groups with varying degrees of coronary artery disease (CAD) and acute myocardial infarction (MI).
  • To evaluate the potential of MMP-9 and hsCRP as biomarkers for plaque instability in ACS.

Main Methods:

  • Serum samples were collected from 150 patients diagnosed with ACS.
  • Patients were categorized into three groups: significant CAD (>50% stenosis), non-significant CAD, and acute MI.
  • Coronary angiography was used to determine the significance of CAD.
  • MMP-9 and hsCRP levels were measured in serum samples.

Main Results:

  • Serum MMP-9 levels were significantly lower in patients without significant CAD compared to those with significant CAD, and lowest in the acute MI group.
  • Serum hsCRP levels were significantly higher in the acute MI group compared to the other two groups.
  • No significant difference in hsCRP levels was observed between patients with and without significant CAD.

Conclusions:

  • MMP-9 serum concentrations correlate with the severity of CAD and MI.
  • hsCRP levels are significantly elevated in acute MI patients.
  • MMP-9 and hsCRP show potential as valuable biomarkers for assessing plaque instability in ACS patients.

More Related Videos

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...